Amyopathic dermatomyositis: Clinical Trials

1 trial for Amyopathic dermatomyositis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Amyopathic dermatomyositis: new trials by email Literature Review of Amyopathic dermatomyositis trials Research Report on Amyopathic dermatomyositis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study
Emapalumab - Dermatomyositis, Dermatomyositis Sine Myositis
Phase 2RecruitingUniversity of Miami52026-07-232026-08-25

Narrower conditions

Dermatomyositis (1)  ·  Lung Diseases, Interstitial (1)

Broader conditions

Connective Tissue Diseases (1)  ·  Lung Diseases (1)  ·  Muscular Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Myositis (1)  ·  Nervous System Diseases (1)  ·  Neuromuscular Diseases (1)  ·  Polymyositis (1)  ·  Respiratory Tract Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Emapalumab (1)

Sponsors

University of Miami (1)

Countries

United States (1)

Top investigators

Kelly Corbitt, D.O. (1)